ID: ALA5268031

Max Phase: Preclinical

Molecular Formula: C21H15F4NO2

Molecular Weight: 389.35

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(NCc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)ccc1F

Standard InChI:  InChI=1S/C21H15F4NO2/c22-19-10-9-17(11-18(19)20(27)28)26-12-13-1-3-14(4-2-13)15-5-7-16(8-6-15)21(23,24)25/h1-11,26H,12H2,(H,27,28)

Standard InChI Key:  CCFAALGSBOBPRB-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.35Molecular Weight (Monoisotopic): 389.1039AlogP: 5.82#Rotatable Bonds: 5
Polar Surface Area: 49.33Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.97CX Basic pKa: 4.65CX LogP: 4.73CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.27

References

1. Lee JJ, Hu Z, Wang YA, Nath D, Liang W, Cui Y, Ma JX, Duerfeldt AS..  (2023)  Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists.,  14  (6): [PMID:37312852] [10.1021/acsmedchemlett.3c00056]

Source